Skip to main content Back to Top


Alprostadil Urethral Suppositories

Products Affected - Description

    • Muse urethral suppository, Mylan, 125 mcg, 6 count, NDC 00037-8110-06 - discontinued

Reason for the Shortage

    • Mylan discontinued Muse 125 mcg suppositories in late-May 2021.

Available Products

    • Muse urethral suppository, Mylan, 1000 mcg, 6 count, NDC 00037-8140-06
    • Muse urethral suppository, Mylan, 250 mcg, 6 count, NDC 00037-8120-06
    • Muse urethral suppository, Mylan, 500 mcg, 6 count, NDC 00037-8130-06

Estimated Resupply Dates

    • Mylan has all marketed presentations available.


Updated June 14, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 21, 2019 by Rachael Freeman, PharmD, BCPS. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.


Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.